Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Return on Invested Capital: 2016-2025

Historic Return on Invested Capital for Theravance Biopharma (TBPH) over the last 4 years, with Sep 2025 value amounting to -0.07%.

  • Theravance Biopharma's Return on Invested Capital was N/A to -0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.07%, marking a year-over-year change of. This contributed to the annual value of -1.53% for FY2022, which is 238.00% down from last year.
  • As of Q3 2025, Theravance Biopharma's Return on Invested Capital stood at -0.07%, which was down 153.59% from -0.03% recorded in Q2 2025.
  • Theravance Biopharma's 5-year Return on Invested Capital high stood at 0.93% for Q1 2021, and its period low was -2.00% during Q3 2022.
  • In the last 2 years, Theravance Biopharma's Return on Invested Capital had a median value of -0.07% in 2025 and averaged -0.09%.
  • Data for Theravance Biopharma's Return on Invested Capital shows a maximum YoY slumped of 289bps (in 2022) over the last 5 years.
  • Theravance Biopharma's Return on Invested Capital (Quarterly) stood at 0.81% in 2021, then tumbled by 101bps to -0.20% in 2022, then reached -0.19% in 2023, then reached -0.07% in 2025.
  • Its Return on Invested Capital was -0.07% in Q3 2025, compared to -0.03% in Q2 2025 and -0.19% in Q1 2023.